Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C Than KIR2DL3

Biochemistry, Genetics and Molecular Biology

• HLA-C 100%
• Binding Site 80%
• Ligand Binding 80%
• Allotype 60%
• Arginine 40%
• HLA-B 40%
• KIR2DL1 40%
• Development 20%
• Regulatory Mechanism 20%
• Site-Directed Mutagenesis 20%
• Mutagenesis 20%
• Position 20%
• Mutant 20%
• Cysteine 20%
• Lysine 20%
• Proline 20%
• Isoform 20%
• HLA-A 20%
• Asparagine 20%
• Avidity 20%
• Cross Reaction 20%
• Immunoglobulin Domain 20%